Pennington, New Jersey
United States
34
2025-05-08
The entities that hold a legal rights for patent applications filed by inventor Meng Wei:
Wei Meng from Pennington, US has applied for patents for these inventions. The list has both pending applications and granted patents:
UBIQUITIN SPECIFIC PROCESSING PROTEASE 1 (USP1) COMPOUNDS
#2 | 2022-10-06Apelin receptor agonists and methods of use
#3 | 2021-07-01Apelin receptor agonists and methods of use
#4 | 2021-06-03ARYL DIHYDROPYRIDINONES AND PIPERIDINONE MGAT2 INHIBITORS
#5 | 2020-09-10Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
#6 | 2019-10-314-hydroxy-3-sulfonylpyridin-2(1H)-ones as APJ receptor agonists
#7 | 2019-10-17Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
#8 | 2019-08-01Glucokinase activators and methods of using same
#9 | 2019-06-276-hydroxy-5-(phenyl/heteroarylsulfonyl)pyrimidin-4(1H)-one as APJ agonists
#10 | 2019-05-162-(benzothiazol-2-yl)-2-cyano-acetamide derivatives and their use as endothelial lipase inhibitors
#11 | 2019-05-02Bridged bicyclic compounds as farnesoid X receptor modulators
#12 | 2019-01-036-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists
#13 | 2018-12-20Heteroarylhydroxypyrimidinones as agonists of the APJ receptor
#14 | 2018-10-182,4-dihydroxy-nicotinamides as APJ agonists
#15 | 2018-05-17Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
#16 | 2017-09-286-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists
#17 | 2017-09-21Dihydropyridinone MGAT2 inhibitors
#18 | 2017-08-03Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
#19 | 2017-01-19Dihydropyridinone MGAT2 inhibitors for use in the treatment of metabolic disorders
#20 | 2016-02-04Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
#21 | 2015-11-05Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
#22 | 2013-06-06Aryl dihydropyridinone and piperidinone MGAT2 inhibitors
#23 | 2013-01-31Glucokinase activators and methods of using same
#24 | 2012-06-07Substituted pyrazolylamides useful as glucokinase activators
#25 | 2011-05-19Substituted pyrazolylamide compounds useful as glucokinase activators
#26 | 2008-03-11Substituted anilide ligands for the thyroid receptor
#27 | 2008-01-10Phosphonate and phosphinate pyrazolylamide glucokinase activators
#28 | 2006-08-10Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and methods
#29 | 2006-06-29Pyrimidine-based inhibitors of dipeptidyl peptidase IV and methods
#30 | 2006-05-252-aminonaphthalene derivatives and related glycogen phosphorylase inhibitors
#31 | 2006-05-252-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
#32 | 2006-05-252-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
#33 | 2006-03-23C-aryl glucoside SGLT2 inhibitors and method
#34 | 2005-08-30C-aryl glucoside SGLT2 inhibitors and method
68272 ⎘